The forecasted data suggests a decline in female mortality due to trachea, bronchus, or lung malignant neoplasms from 2024 to 2028. The value, measured in thousands, changes from 57.84 in 2024 to 52.65 in 2028. This represents a gradual decrease in mortality rates. Assuming the actual figure from 2023 is 59, the annual decline is approximately 2.2% from 2024 to 2025, and the average yearly reduction over the five-year period (CAGR) is nearly 3%.
Looking forward, it is crucial to monitor the effects of advancements in medical treatments and early detection methodologies. Additionally, public health policies aiming at reducing smoking rates and controlling environmental pollutants could significantly influence future trends.
